ROSEN, NATIONAL TRIAL LAWYERS, Encourages Seagate Technology Holdings plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – STX
NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of Seagate Technology Holdings plc (NASDAQ:
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Proterra Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PTRA
NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Proterra Inc. (NASDAQ: PTRA) between August 2,
ROSEN, A TOP RANKED LAW FIRM, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – DHR
NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Danaher Corporation (NYSE: DHR) between April 21,
EB5 Capital’s Riverfront at the Navy Yard (JF8) Project Receives First I-829 Approval
WASHINGTON, July 24, 2023 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce that it has received notice from the United States Citizenship and Immigration Services (USCIS) regarding the first
APLS INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – APLS
NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders
Curia expands biologics capabilities with access to Touchlight’s doggybone DNA
Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA™) ALBANY, N.Y. and HAMPTON, United Kingdom, July 24, 2023 (GLOBE NEWSWIRE) —